Hospital M&A in 2015

It’s been a busy year for mergers and acquisitions in the Hospital sector, and it’s not over yet. Our preliminary figures show 101 transactions with a combined deal value of $8.7 billion. At least two announced transactions have been terminated, and there are still a few to track down, so those numbers will change. Of those 101 deals, 89 acquirers were other hospitals or health systems. One was a behavioral health company, Sovereign Health Group, which runs residential treatment centers for mental health and substance abuse patients through its affiliate, Ashland Properties LLC. Private equity firms made six acquisitions, and REITs made five. The largest of those REIT... Read More »

Shryver Medical and Revelstoke Capital Double Down in Texas

Schryver Medical LLC, a portfolio company of Revelstoke Capital Partners, announced two acquisitions in Texas in late December. Community Portable X-Ray, Inc., as its name implies, provides mobile x-ray and other imaging services to long-term health care facilities, home care, psychiatric hospitals, industrial sites, dialysis centers and athletic teams. Besides its base in Plano, it also has operations in Fort Worth, Houston and San Antonio. The second acquisition is a combination of MetroStat Clinical Laboratory Inc. and MetroStat Diagnostic Services (collectively, MetroStat). MetroStat provides digital ultrasound and EKG teleradiology equipment that allow its technologists to obtain the... Read More »

WellSpan Ups Its Behavioral Health Offerings

The Behavioral Health Care sector has seen plenty of mergers and acquisitions this year. Deal volume is currently up 38% (33 deals) compared with 2014’s full-year total of 24 transactions. With six deals announced in December, the sector will close out the year on a high note. One deal has been in the works almost all year, and will become effective on January 1, 2016. WellSpan Health, a five-hospital system based in York, Pennsylvania, and Philhaven, a mental and behavioral health agency of the Lancaster Conference of the Mennonite Church USA, finalized their affiliation plans on December 17. Philhaven provides services throughout Lancaster, Lebanon, Dauphin, and York counties. The... Read More »

Martin Shkreli, We Hardly Knew Ye

Actually, we know Martin Shkreli, CEO of KaloBios Pharmaceuticals (NASDAQ: KBIO), all too well. The brash young man was arrested by the Federal Bureau of Investigations yesterday in Manhattan, on charges of fraud relating to his days at a hedge. Just weeks before, as then-CEO of privately held Turing Pharmaceuticals, he became the poster child of drug price gougers, having boosted the price of a long-marketed generic drug by 5000%, from $13.50 per pill to $750. The revelations in a New York Times story brought swift recriminations from all sides, including presidential candidates. The most striking note for us, as health care database wonks, is that Shkreli launched his first biotech... Read More »